Decoding CDI: How is C. difficile Diagnosed?
Published: May 25, 2024
Diagnosing Clostridioides difficile infection (CDI) can be tricky, but understanding the tests involved can help demystify the process.
Contents
The Gold Standard: NAAT
The nucleic acid amplification test (NAAT) is a highly sensitive method used to detect the presence of C. difficile toxins in stool samples. This test can quickly identify the infection and is often combined with enzyme immunoassays to ensure accuracy. However, it cannot differentiate between active infections and carriers of the bacteria.
Other Testing Methods
Enzyme immunoassays for toxins A and B provide another way to diagnose CDI. Although less sensitive than NAAT, they are quick and can confirm the presence of toxins. Selective anaerobic culture is another method, though it's slower and more labor-intensive, primarily used for research purposes.

When is Testing Needed?
Testing is crucial for patients with unexplained diarrhea and relevant risk factors like antibiotic use. Only liquid stool samples from symptomatic patients should be tested to avoid false positives. In cases of ileus, where diarrhea is absent, specific rectal swabs may be used for diagnosis.
Frequently Asked Questions
NAAT is a sensitive test for detecting C. difficile toxins.
Yes, enzyme immunoassays and anaerobic cultures are also used.
Testing should be done for patients with unexplained diarrhea.
Key Takeaways
Understanding CDI tests can lead to quicker and more accurate diagnoses.
Get started: Consult Doctronic to learn more about CDI testing options.Related Articles
References
Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257.
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372:1539.
Always discuss health information with your healthcare provider.